Stocks/TSX-V/LSL

LSL Pharma Group Inc. (LSL : TSX-V)

Common Stock

$0.32

CAD

+0.00 (%)

Last updated: 2026-07-02

LSL

LSL Pharma Group Inc.

Source:WealthAwesomeWealthAwesome
$0.03 (-10.00%)
30 day period
$0.30$0.33$0.35May 21Jun 11Jul 2

Performance

1 Day

+0.00%

1 Week

+3.28%

1 Month

-4.55%

YTD

-10.00%

Key Statistics

Market Cap

$39.92M

52W High

$0.56

52W Low

$0.30

P/E Ratio

-

50 Day MA

$0.35

200 Day MA

$0.39

Beta

-0.50

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/2/2026$0.32$0.32$0.32$0.32$0.325,500
6/30/2026$0.32$0.32$0.31$0.32$0.3228,000
6/29/2026$0.32$0.32$0.30$0.30$0.30214,647
6/26/2026$0.31$0.31$0.30$0.30$0.30320,000
6/25/2026$0.32$0.32$0.30$0.30$0.30148,500
6/24/2026$0.33$0.33$0.32$0.32$0.32118,500
6/23/2026$0.32$0.33$0.32$0.32$0.3254,616
6/22/2026$0.31$0.32$0.30$0.32$0.32104,320
6/19/2026$0.31$0.32$0.31$0.32$0.32176,200
6/18/2026$0.32$0.32$0.31$0.31$0.3139,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on LSL's historical volatility

HistoricalForecast68%95%
C$0.17C$0.24C$0.30C$0.37C$0.43C$0.49TodayFeb 23Apr 29Jul 2Aug 14Sep 27Nov 9

30-Day Vol

32.6%

Annualized

90-Day Vol

40.3%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.26

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.30C$0.27C$0.33
60 trading daysC$0.28C$0.24C$0.33
90 trading daysC$0.26C$0.22C$0.32

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About LSL Pharma Group Inc.

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Financials

Revenue (TTM)
$26.80M
EBITDA
$3.80M
Profit Margin
10.35%
ROE (TTM)
12.13%
EPS (Diluted)
-0.04
Book Value
0.22

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

Advertisement

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About LSL

Advertisement